LMAT LeMaitre Vascular Inc.

LeMaitre to Participate at Upcoming Investor Conferences in September

LeMaitre to Participate at Upcoming Investor Conferences in September

BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in four upcoming investor conferences.

2025 Wells Fargo Healthcare Conference

Wednesday, September 3, 2025

Encore Boston Harbor, Everett, MA

Dorian LeBlanc, CFO, will present at 1:30 PM ET

Cantor Global Healthcare Conference

Thursday, September 4, 2025

InterContinental New York Barclay Hotel, New York, NY

Dorian LeBlanc, CFO, will present at 10:55 AM ET

Morgan Stanley 23rd Annual Global Healthcare Conference

Tuesday, September 9, 2025

Sheraton New York Times Square, New York, NY

Dorian LeBlanc, CFO, will present at 3:20 PM ET

Barrington Research Fall Investment Conference (Virtual)

Tuesday, September 16, 2025

Dorian LeBlanc, CFO, time to be announced

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.



Contact:
Sandra Millar
LeMaitre Vascular, Inc.
EN
28/08/2025

Underlying

LMATLeMaitre Vascular Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LeMaitre Vascular Inc.

 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre to Participate at Upcoming Investor Conferences in September

LeMaitre to Participate at Upcoming Investor Conferences in September BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in four upcoming investor conferences. 2025 Wells Fargo Healthcare Conference Wednesday, September 3, 2025 Encore Boston Harbor, Everett, MA Dorian LeBlanc, CFO, will present at 1:30 PM ET Cantor Global Healthcare Conference Thursday, September 4, 2025 InterContinental New York Barclay Hotel, New York, NY Dorian LeBlanc, CFO, will present at 10:55 AM ET Morgan Stanley 23rd ...

4h / 52m 1 EN
 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, ...

LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025 BURLINGTON, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online . All registrants will receive dial-in information and a PIN allowing them to access the live call....

July 8, 2025 1 EN
 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre to Present at the Bank of America Securities 2025 Healthcare ...

LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference BURLINGTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Bank of America Securities 2025 Healthcare Conference on Tuesday, May 13, 2024, at 5:00 PM PDT at the Encore at the Wynn Hotel in Las Vegas, NV. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, m...

May 5, 2025 1 EN
 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre Q1 2025 Financial Results

LeMaitre Q1 2025 Financial Results BURLINGTON, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance. Q1 2025: Sales $59.9mm, +12% (+13% organic)Gross margin 69.2%, +60 bpsOp. income $12.6mm, +6%Op. margin 21%Earnings per diluted share $0.48, +10%Cash up $2.8mm sequentially to $302.5mm Grafts (+17%) and carotid shunts (+14%) drove sales growth. EMEA sales increased 18%, Americas 11%, and APAC 3%. Gross ma...

May 1, 2025 1 EN
 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025

LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025 BURLINGTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2025 financial results on Thursday, May 1, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online . All registrants will receive dial-in information and a PIN allowing them to access the live call. The a...

April 7, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch